Ranked among the top centers in the nation for cancer services according to U.S. News & World Report, Duke Cancer Institute (DCI) is a recognized leader in developing new drugs, cancer vaccines, and novel approaches to treating cancer and related symptoms through ongoing clinical trials. It offers a level of cancer expertise and experience only found in the top four percent of U.S. centers designated as a National Cancer Institute Comprehensive Cancer Center. The Institute is part of Duke Health, which is in the midst of a historic five-year, $1.2 billion fundraising campaign to cement its position as a global leader in discovery, clinical care, and education.